Clinical Challenges: Test Your Knowledge on Dry Eye Disease

Dry eye disease (DED) is a very common, chronic condition that affects at least 5% of U.S. adults.

The following quiz tests aspects from each article in our three-part “Clinical Challenges” series on this often progressive disease: how a new prescription eye drop may change DED treatment, the impact of prescribing on DED, and the safety of over-the-counter eye drops.

Correct answers and explanations will appear after completing the quiz.

Mark Fuerst is a Contributing Writer for MedPage Today who primarily writes about oncology and hematology. Follow

Psyence Biomed Announces Initiation of First Trial Site in Australia for its Phase IIb Study of Nature Derived Psilocybin as a Potential Treatment for Adjustment Disorder in Palliative Care | Psychedelic Invest

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”), a developer of naturally derived psilocybin-based therapeutics,

September 12, 2024

Spectral AI Appoints Peter M. Carlson as CEO

Peter M Carlson, CEO at Spectral AI What You Should Know: – Spectral AI, Inc. (Nasdaq: MDAI), a leader in AI-powered wound care diagnostics, announced

March 2, 2024

New biomarker could help predict Parkinson’s disease progression

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson’s disease progression.

November 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.